These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28534127)

  • 1. Genetics of Triglycerides and the Risk of Atherosclerosis.
    Dron JS; Hegele RA
    Curr Atheroscler Rep; 2017 Jul; 19(7):31. PubMed ID: 28534127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of hypertriglyceridemia and atherosclerosis.
    Gill PK; Dron JS; Hegele RA
    Curr Opin Cardiol; 2021 May; 36(3):264-271. PubMed ID: 33818545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
    Lanktree MB; Thériault S; Walsh M; Paré G
    Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication.
    Chasman DI; Paré G; Zee RY; Parker AN; Cook NR; Buring JE; Kwiatkowski DJ; Rose LM; Smith JD; Williams PT; Rieder MJ; Rotter JI; Nickerson DA; Krauss RM; Miletich JP; Ridker PM
    Circ Cardiovasc Genet; 2008 Oct; 1(1):21-30. PubMed ID: 19802338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.
    Weissglas-Volkov D; Aguilar-Salinas CA; Sinsheimer JS; Riba L; Huertas-Vazquez A; Ordoñez-Sánchez ML; Rodriguez-Guillen R; Cantor RM; Tusie-Luna T; Pajukanta P
    Circ Cardiovasc Genet; 2010 Feb; 3(1):31-8. PubMed ID: 20160193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol.
    Georgakis MK; Malik R; Anderson CD; Parhofer KG; Hopewell JC; Dichgans M
    Brain; 2020 Feb; 143(2):597-610. PubMed ID: 31968102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.
    Hindy G; Engström G; Larsson SC; Traylor M; Markus HS; Melander O; Orho-Melander M;
    Stroke; 2018 Apr; 49(4):820-827. PubMed ID: 29535274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
    Vitali C; Khetarpal SA; Rader DJ
    Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of plasma triglycerides.
    Johansen CT; Kathiresan S; Hegele RA
    J Lipid Res; 2011 Feb; 52(2):189-206. PubMed ID: 21041806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
    Handelsman Y; Shapiro MD
    Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a two-sample Mendelian randomization design to investigate a possible causal effect of maternal lipid concentrations on offspring birth weight.
    Hwang LD; Lawlor DA; Freathy RM; Evans DM; Warrington NM
    Int J Epidemiol; 2019 Oct; 48(5):1457-1467. PubMed ID: 31335958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications.
    Akivis Y; Alkaissi H; McFarlane SI; Bukharovich I
    Curr Cardiol Rev; 2024; 20(2):39-49. PubMed ID: 38288833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein-CIII
    Naber A; Demus D; Slieker R; Nicolardi S; Beulens JWJ; Elders PJM; Lieverse AG; Sijbrands EJG; 't Hart LM; Wuhrer M; van Hoek M
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic and phenotypic spectrum of plasma triglycerides.
    Johansen CT; Hegele RA
    Biochim Biophys Acta; 2012 May; 1821(5):833-42. PubMed ID: 22033228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
    St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
    Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study.
    Huggins GS; Papandonatos GD; Erar B; Belalcazar LM; Brautbar A; Ballantyne C; Kitabchi AE; Wagenknecht LE; Knowler WC; Pownall HJ; Wing RR; Peter I; McCaffery JM;
    Circ Cardiovasc Genet; 2013 Aug; 6(4):391-9. PubMed ID: 23861364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization of blood lipids for coronary heart disease.
    Holmes MV; Asselbergs FW; Palmer TM; Drenos F; Lanktree MB; Nelson CP; Dale CE; Padmanabhan S; Finan C; Swerdlow DI; Tragante V; van Iperen EP; Sivapalaratnam S; Shah S; Elbers CC; Shah T; Engmann J; Giambartolomei C; White J; Zabaneh D; Sofat R; McLachlan S; ; Doevendans PA; Balmforth AJ; Hall AS; North KE; Almoguera B; Hoogeveen RC; Cushman M; Fornage M; Patel SR; Redline S; Siscovick DS; Tsai MY; Karczewski KJ; Hofker MH; Verschuren WM; Bots ML; van der Schouw YT; Melander O; Dominiczak AF; Morris R; Ben-Shlomo Y; Price J; Kumari M; Baumert J; Peters A; Thorand B; Koenig W; Gaunt TR; Humphries SE; Clarke R; Watkins H; Farrall M; Wilson JG; Rich SS; de Bakker PI; Lange LA; Davey Smith G; Reiner AP; Talmud PJ; Kivimäki M; Lawlor DA; Dudbridge F; Samani NJ; Keating BJ; Hingorani AD; Casas JP
    Eur Heart J; 2015 Mar; 36(9):539-50. PubMed ID: 24474739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: the Strong Heart Family Study.
    Li X; Monda KL; Göring HH; Haack K; Cole SA; Diego VP; Almasy L; Laston S; Howard BV; Shara NM; Lee ET; Best LG; Fabsitz RR; MacCluer JW; North KE
    J Med Genet; 2009 Jul; 46(7):472-9. PubMed ID: 19429595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients.
    Brisson D; Ledoux K; Bossé Y; St-Pierre J; Julien P; Perron P; Hudson TJ; Vohl MC; Gaudet D
    Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution.
    Patel AP; Peloso GM; Pirruccello JP; Johansen CT; Dubé JB; Larach DB; Ban MR; Dallinge-Thie GM; Gupta N; Boehnke M; Abecasis GR; Kastelein JJ; Hovingh GK; Hegele RA; Rader DJ; Kathiresan S
    Atherosclerosis; 2016 Jul; 250():63-8. PubMed ID: 27182959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.